Kelly Michael Aaron 4
Research Summary
AI-generated summary
NEOGENOMICS (NEO) Director Kelly Michael Aaron Receives/Exercises Shares
What Happened
- Director Kelly Michael Aaron reported conversion/exercise and award activity on June 1, 2026. The filing shows conversion/exercise (code M) of 23,077 shares at $0.00, a matching derivative disposal of 23,077 shares at $0.00, and two award/grant entries (code A) for 11,069 and 15,970 shares at $0.00. Gross shares acquired across the entries total 50,116 shares; the filing records a simultaneous disposal of 23,077 shares. All reported transactions have $0 total consideration.
Key Details
- Transaction date: 2026-06-01; Form 4 filed 2026-06-03 (filed two days after the transactions).
- Reported prices: $0.00 for all entries; total cash exchanged reported = $0.
- Shares listed: Acquired = 23,077 (exercise/conversion) + 11,069 (award) + 15,970 (award) = 50,116; Disposed = 23,077.
- Shares owned after the transactions: not disclosed in the data provided.
- Footnotes: F1 — reflects release of restricted stock units (RSUs) previously reported on a Form 4. F2 — once vested, the shares of common stock are not subject to expiration.
- No 10b5-1 plan or late-filing flag noted in the provided data.
Context
- The entries are derivative-related (exercise/conversion and awards) and reflect issuance/release of previously granted RSUs or similar awards rather than an open-market buy or sale. A same-day "disposed" entry often appears alongside conversions to reflect share surrender/withholding, but the filing itself does not state the reason. These transactions are routine for vesting/settlement of equity awards and do not directly indicate a market-direction trade by the insider.